Disseminated coccidioidomycosis
Medical condition
From Wikipedia, the free encyclopedia
Disseminated coccidioidomycosis is a systemic infection caused by Coccidioides immitis. 15-20% of people with the infection develop skin lesions.[1]: 315
| Disseminated coccidioidomycosis | |
|---|---|
| Other names | Coccidioidal granuloma |
| |
| Characteristic skin granulomata on the forehead. | |
| Specialty | Infectious diseases |
History of treatment
One of the earliest treatments for the disease was publicized in the New York State Journal of Medicine in 1959, in an article titled "Disseminated Coccidioidomycosis Treated with Amphotericin B". The case centered around a patient who was admitted to the U.S. Public Health Service Hospital in Seattle, Washington. Before the introduction of Amphotericin B, disseminated coccidioidomycosis had no specific chemotherapeutic treatment. Amphotericin B, a polyene antifungal, was first trialed for this condition approximately three years earlier. Since then, multiple reports have highlighted the medication's clinical effectiveness in patients with coccidioidomycosis. [2]